Article
Blood copper and risk of cardiometabolic diseases: a Mendelian randomization study.
Human molecular genetics - 3 Mar 2022
Jäger Susanne, Cabral Maria, Kopp Johannes F, Hoffmann Per, Ng Esther, Whitfield John B, Morris Andrew P, Lind Lars, Schwerdtle Tanja, Schulze Matthias B
Abstract excerpt
Observational evidence links higher blood levels of copper with higher risk of cardiovascular diseases. However, whether those associations reflect causal links or can be attributed to confounding is still not fully clear. We investigated causal effects of copper on the risk of cardiometabolic endpoints (stroke, coronary artery disease [CAD] and type 2 diabetes) and cardiometabolic risk factors in two-sample...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
